Car-Sharing Startup Getaround Raises $140 Million as Business Recovers From Pandemic Low | Investing News

(Reuters) – Car-sharing company Getaround Inc on Wednesday said it has raised $140 million in additional venture capital funding at a time when its business is seeing growing demand and recovering from a collapse during the early days of the coronavirus pandemic.

The San Francisco-based company, backed by Japan’s SoftBank Group Corp <9984.T>, has raised a total of nearly $600 million since it was founded more than ten years ago and in previous rounds was valued at more than $1.5 billion.

The company allows private vehicle owners to rent out their cars through Getaround’s platform on an hourly or daily basis and operates in over 100 U.S. cities and more than 170 European locations after the company acquired a local competitor in 2019.

Getaround’s business suffered during the initial outbreak of the novel coronavirus in March and April, when demand dropped 75% and the company sought financial support from a

Read More

Medtronic highlights development strategy; raises revenue growth outlook (NYSE:MDT)

Medtronic (NYSE:MDT) will outline its strategy for driving accelerated revenue growth and sustainable double-digit total shareholder returns at its virtual 2020 Investor Day. The strategy includes:

The combination of a strong base business, recent product launches and a robust pipeline is expected to accelerate near- and long-term growth.

Medtronic is bringing inventive and disruptive technology with products such as soft tissue surgical robot, its Micra line of leadless pacemakers, extravascular ICD, pulse field ablation, PillCam Genius, transcatheter mitral replacement and repair, and renal denervation (RDN). RDN has been granted Green Channel priority review, which positions it for potential approval in China within a few months of an expected U.S. approval in calendar 2022.

The company has a differentiated R&D strategy that maximizes new technology, artificial intelligence, and analytics to deliver innovations to address unmet clinical needs.

Medtronic will provide an update on its long-range financial targets. The financial objectives include:

Read More